replimune.com (REPL) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Replimune Group, Inc. (REPL)

Replimune Group, Inc. (REPL) is developing a scalable oncolytic virus platform where current losses are offset by high-margin potential. The cash-on-hand metric reflects liquidity dynamics, while 0.31 determines the latest valuation figure. Innovations in melanoma treatment support expectations for premium pricing power. The absence of stable cash flow leaves the company dependent on external financing and partnerships.

REPL - Cadangan dhuwit perusahaan Replimune Corp ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Replimune Group, Inc.

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Replimune Group Inc REPL
Produk merek Replimune

Cash volume represents the aggregate balance of liquid assets that determines the issuer's financial stability. This metric captures the real-time status of accounts, allowing for a prompt assessment of the capital's safety margin or stagnation. By analyzing changes in cash holdings, an investor can track the burn rate of resources allocated to R&D. For Replimune Group, Inc. (REPL), this is critical, as the funding for the development of oncolytic viruses paves the way for a high-profit market launch of its drugs.

Pesaing Replimune Group, Inc. (REPL)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Lyell Immunopharma, Inc. (LYEL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan